by Sowmya Viswanathan | Jun 26, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
by Jovana Drinjakovic | Jun 15, 2018
Plagued by failures of early human studies from the 1990s, including the death of a patient, gene therapy is making a comeback with promising results. And it has a tiny virus to thank. After the first 2012 European gene therapy approval for a liver disease, and last...
by Stacey Johnson | May 11, 2018
For Canada to thrive, supporting and training our future work force and leaders is crucial. This can happen in a myriad of ways. For a group of Canadian organizations in the biotherapeutics field, this has taken the form of joining together to host training workshops...
by Stacey Johnson | Mar 30, 2018
Canada’s reputation for excellent science in the field of regenerative medicine can be traced back to the University of Toronto (U of T). Quite literally, Drs. James Till and Ernest McCulloch were U of T researchers when they discovered stem cells in the early 1960s....
by Stacey Johnson | Feb 2, 2018
Cell and Gene Therapy World, or “Phacilitate” as delegates like to refer to it, happened last week in Miami, Florida (January 22-25). The conference, with 1,500 in attendance, brings together industry professionals from more than 30 countries. The event...
by Nicole Kuchinsky | Dec 5, 2017
One of my personal highlights from this year’s Till and McCulloch Meetings was attending the “Science for Citizens” panel (reported on in a previous post). Experts including Timothy Caulfield, patient advocate William Brock, and National Post writer Tom...
Comments